Genetic, metabolic score stratifies risk for adverse events in fatty liver

Using genetic markers with metabolic risk factors can predict an individual patient’s risk for developing liver related events due to non-alcoholic fatty liver disease, according to a researcher at The Liver Meeting Digital Experience.“In NAFLD patients with significant fibrosis, the genetic metabolic staging score combining demographic and metabolic features with common genetic variants accurately predicts the risk for liver-related events,” Grazia Pennisi, PhD student at the University of Palermo, Italy, said in her presentation.Pennisi presented the Genetic MetabolicRead More

Share on facebook
Share on twitter
Share on linkedin